This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Background and Date of Approval

Sitagliptin + Metformin was initially approved by the U.S. Food and Drug Administration (FDA) on March 30, 2007. 

Mechanism of Action of undefined

Sitagliptin + Metformin combines its two active ingredients, which act synergistically. Sitagliptin enhances insulin release and reduces glucagon levels, while metformin decreases liver glucose production and enhances peripheral glucose uptake. Together, they help control blood sugar levels in individuals with type 2 diabetes.

Uses of undefined

Sitagliptin + Metformin is primarily used to manage type 2 diabetes by controlling blood sugar levels and enhancing insulin release. It aids postprandial glucose control and may assist in weight management without significant weight gain. Additionally, it may contribute to improved cardiovascular health when incorporated into a comprehensive diabetes management plan. 

undefined Drug administaration and Dosage available

Sitagliptin + Metformin can be administered orally. Follow the prescribed dosage and any additional instructions provided by the healthcare professional for the safe and effective use of Sitagliptin + Metformin.

Warnings, Precautions and Side Effects of undefined

Warnings

Lactic Acidosis is a rare but serious complication that can occur due to metformin accumulation after taking Sitagliptin + Metformin. Symptoms may include muscle pain, difficulty breathing, stomach discomfort, dizziness, and unusual sleepiness. In some cases, pancreatitis, characterized by severe abdominal pain that may radiate to the back, can occur.

Precautions

Inform your healthcare provider immediately if you experience any symptoms of lactic acidosis after Sitagliptin + Metformin, especially if you have underlying conditions that may predispose you to this complication. Contact your healthcare provider immediately if you develop persistent and severe abdominal pain, which could be a sign of pancreatitis.

Side Effects

Sitagliptin + Metformin may cause common side effects such as diarrhea, nausea, vomiting, gas, and stomach upset. More serious side effects include lactic acidosis, characterized by muscle pain and difficulty breathing, pancreatitis with severe abdominal pain, and hypoglycemia, leading to dizziness and confusion. 

Word Of Advice

Watch for signs of allergies like rash or swelling after taking Sitagliptin + Metformin. Regularly check how well your kidneys and liver are working. If you have any heart problems, be careful while using this medication. Pay attention to signs like feeling shaky or dizzy, which might mean your blood sugar is too low. Be aware of any new infections or if you feel sick.  If you are pregnant or breastfeeding, talk to your doctor before taking it. Tell your doctor if you have any surgeries coming up. It is better to avoid too much alcohol while taking this medication. Make sure to drink enough water, especially if you are sick. Long-term use of this medication might affect your vitamin levels, so ask your doctor about it. Along with taking the medication, maintain a healthy diet and stay physically active as your doctor advises. Manage your stress levels and get enough rest to support your overall well-being.

Frequently Asked Question

References

  1. Merck Sharp & Dohme (UK) Limited, Electronic Medicines Compendium (EMC), [Revised on February 2022] [Accessed on 27th Oct  2023], https://www.medicines.org.uk/emc/files/pil.564.pdf
  2. Merck Sharp & Dohme Corp., U.S. Food and Drug Administration, [Accessed on 27th Oct  2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022044s022lbl.pdf
  3. KD Tripathi, Essentials of Medical Pharmacology, Hormones and Related Drugs, 7th edition, 2013, 274-276

Disclaimer

The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.